You are using an older browser version. Please use a supported version for the best MSN experience.

Edesa Biotech, Inc.

NASDAQ: EDSA
7.24
-0.50
-6.46%

Sector

Healthcare

Industry

Biotechnology & Medical Research

Edesa Biotech Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing clinical-stage drugs for dermatological and gastrointestinal indications. Its lead product candidate, EB01, is an sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD). Its pipeline also includes EB02 and EB04. EB02, an sPLA2 inhibitor, is being developed as a treatment for patients with hemorrhoids disease (HD). EB04 is being developed for anal fissures. It is also focused on developing biologic drug candidates for therapeutic, prophylactic and diagnostic applications.

Key People

Frank R. Oakes

Director

Kathi Niffenegger

Chief Financial Officer, Secretary

Sean Arthur MacDonald

Independent Chairman of Board

Michael J Brooks

President

Pardeep Nijhawan

Chief Executive Officer, Director

Incorporated

2009

Employees

10

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 5/27/2020

    • BROOKS MICHAEL J PH.D.

    • Bought

    • 2,500

    • 3.00

    • 7,500.00

    • 5/26/2020

    • NIJHAWAN PARDEEP

    • Bought

    • 3,000

    • 2.98

    • 8,939.10

    • 3/17/2020

    • NIJHAWAN PARDEEP

    • Bought

    • 5,000

    • 1.90

    • 9,489.00

    • 1/8/2020

    • JOHNSON LORIN K.

    • Grant

    • 8,524

    • 3.15

    • 26,850.60

    • 1/8/2020

    • BROOKS MICHAEL J PH.D.

    • Grant

    • 1,827

    • 3.15

    • 5,755.05

    • 1/8/2020

    • SISTILLI, CARLO

    • Grant

    • 2,436

    • 3.15

    • 7,673.40

    • 1/8/2020

    • VAN DER VELDEN, PETER

    • Grant

    • 140,625

    • 3.20

    • 450,000.00

    • 1/8/2020

    • NIFFENEGGER, KATHI JO

    • Grant

    • 1,218

    • 3.15

    • 3,836.70

    • 1/8/2020

    • OAKES, FRANK R

    • Grant

    • 1,218

    • 3.15

    • 3,836.70

    • 1/8/2020

    • NIJHAWAN PARDEEP

    • Grant

    • 9,255

    • 3.15

    • 29,153.25

    • 1/8/2020

    • PAY PAUL WILLIAM

    • Grant

    • 2,436

    • 3.15

    • 7,673.40

    • 9/11/2019

    • OAKES, FRANK R

    • Sold

    • 1,809

    • 5.72

    • 10,345.13

    • 7/26/2019

    • MACDONALD SEAN ARTHUR

    • Grant

    • 786

    • NA

    • NA

    • 7/26/2019

    • VAN DER VELDEN, PETER

    • Grant

    • 101,606

    • NA

    • NA

    • 7/26/2019

    • NIJHAWAN PARDEEP

    • Grant

    • 161,116

    • NA

    • NA

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 5/27/2020

      • BROOKS MICHAEL J PH.D.

      • Bought

      • 2,500

      • 3.00

      • 7,500.00

      • 5/26/2020

      • NIJHAWAN PARDEEP

      • Bought

      • 3,000

      • 2.98

      • 8,939.10

      • 3/17/2020

      • NIJHAWAN PARDEEP

      • Bought

      • 5,000

      • 1.90

      • 9,489.00

      • 1/8/2020

      • JOHNSON LORIN K.

      • Grant

      • 8,524

      • 3.15

      • 26,850.60

      • 1/8/2020

      • BROOKS MICHAEL J PH.D.

      • Grant

      • 1,827

      • 3.15

      • 5,755.05

      • 1/8/2020

      • SISTILLI, CARLO

      • Grant

      • 2,436

      • 3.15

      • 7,673.40

      • 1/8/2020

      • VAN DER VELDEN, PETER

      • Grant

      • 140,625

      • 3.20

      • 450,000.00

      • 1/8/2020

      • NIFFENEGGER, KATHI JO

      • Grant

      • 1,218

      • 3.15

      • 3,836.70

      • 1/8/2020

      • OAKES, FRANK R

      • Grant

      • 1,218

      • 3.15

      • 3,836.70

      • 1/8/2020

      • NIJHAWAN PARDEEP

      • Grant

      • 9,255

      • 3.15

      • 29,153.25

      • 1/8/2020

      • PAY PAUL WILLIAM

      • Grant

      • 2,436

      • 3.15

      • 7,673.40

      • 9/11/2019

      • OAKES, FRANK R

      • Sold

      • 1,809

      • 5.72

      • 10,345.13

      • 7/26/2019

      • MACDONALD SEAN ARTHUR

      • Grant

      • 786

      • NA

      • NA

      • 7/26/2019

      • VAN DER VELDEN, PETER

      • Grant

      • 101,606

      • NA

      • NA

      • 7/26/2019

      • NIJHAWAN PARDEEP

      • Grant

      • 161,116

      • NA

      • NA

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon